Send us a text

Take a journey with us through the realms of science and medicine with Reid Robinson, MD MBA in this powerful conversation about the current state of legalized psychedelic therapies and the power they have in a clinical setting. 
 
 We dive into: 
 
 The unexpected power of a firsthand psychedelic experience
 Ketamine assisted psychotherapy
 The impacts of trauma
 The ethics of capitalism in the psychedelic space 
 
 In our delightful ongoing exploration of duality, this episode complements our love of the woo in a grounded and pragmatic way. 
 
Reid Robison, MD MBA, is a board-certified psychiatrist and Chief Medical Officer at Novamind, an organization focused on evidence-based psychedelic treatments. Reid serves as Medical Director of Center for Change, an Eating Disorder treatment program in Utah. He is the co-developer of the Emotion-Focused Ketamine-assisted Psychotherapy model. Reid is currently the coordinating investigator for the MAPS-sponsored study MDMA assisted psychotherapy study of eating disorders. To date, Reid has guided thousands of ketamine therapy journeys and hundreds of Spravato (esketamine) dosing sessions and provides medical support and psychedelic therapy at plant medicine retreats abroad.